WCM
AVNS icon

Windsor Capital Management’s Avanos Medical AVNS Stock Holding History

Windsor Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-29
Closed – – 128
2015
Q3 		$0 Buy
+29
New +$1.01K ﹤0.01% 568

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Windsor Capital Management's AVNS Position: Q4 2015 in Review

Windsor Capital Management sold out of Avanos Medical (AVNS) in Q4 2015, closing a stake of 29 shares.

Windsor Capital Management first reported a position in AVNS in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 349 funds tracked by Wall St. Rank hold AVNS as of Q4 2015.

  • Windsor Capital Management reported no remaining Avanos Medical position as of Q4 2015 after selling out during the quarter.
  • Windsor Capital Management sold 29 Avanos Medical shares in Q4 2015.
  • Windsor Capital Management first reported a position in Avanos Medical in Q3 2015 and held it in 1 quarter.
  • Windsor Capital Management's Avanos Medical position peaked at $0 in Q3 2015.
  • 349 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2015.

Based on Windsor Capital Management's 13F filing for Q4 2015, filed 1 Feb 2016.